Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus

References

1. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. 1991; The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184:645–654
   [Google Scholar]
2. Cammack N., Phillips A., Dunn G., Patel V., Minor P. D. 1988; Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167:507–514
   [Google Scholar]
3. Cooper P. D. 1977; Genetics of picomaviruses. In Comprehensive Virology vol 9 pp 133–208 Edited by Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
   [Google Scholar]
4. Crainic R., Furione M., Otelea D., Guillot S., Balanant J., Aubert-Combiescu A., Combiescu M., Candrea A. 1992; Natural evolution of oral vaccine poliovirus strains. In Measles and Poliomyelitis Vaccines and Immunization pp 339–358 Edited by Kurstak E. Vienna & New York: Springer-Verlag;
   [Google Scholar]
5. Fichot O., Girard M. 1990; An improved method for sequencing of RNA templates. Nucleic Acids Research 18:6162
   [Google Scholar]
6. Furione M., Guillot S., Otelea D., Balanant J., Candrea A., Crainic R. 1993; Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199–208
   [Google Scholar]
7. Georgescu M.-M., Delpeyroux F., Tardy-Panit M., Balanant J., Combiescu M., Aubert-Combiescu A., Guillot S., Crainic R. 1994; High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. Journal of Virology 68:8089–8101
   [Google Scholar]
8. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. 1982; Rapid evolution of RNA genomes. Science 215:1577–1585
   [Google Scholar]
9. Hughes P. J., North C., Jellis C. H., Minor P. D., Stanway G. 1989; The complete nucleotide sequence of coxsackievirus A21. Journal of General Virology 70:2943–2952
   [Google Scholar]
10. Kawamura N., Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. 1989; Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. Journal of Virology 63:1302–1309
    [Google Scholar]
11. Kew O. M., Nottay B. K. 1984; Evolution of the oral poliovaccine strains in humans occur by both mutation and intramolecular recombination. In Modern Approaches to Vaccines pp 357–367 Edited by Chanock R., Lerner R. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
12. Kohara M., Omata T., Kameda A., Semler B. L., Itoh H., Wimmer E., Nomoto A. 1985; In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. Journal of Virology 53:786–792
    [Google Scholar]
13. Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. 1988; A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. Journal of Virology 62:2828–2835
    [Google Scholar]
14. Lai M. M. C. 1992; RNA recombination in animal and plant viruses. Microbiological Reviews 56:61–79
    [Google Scholar]
15. Lipskaya G. Y., Muzychenko A. R., Kutitova O. K., Maslova S. V., Equestre M., Drozdov S. G., Perez Bercoff R., Agol V. I. 1991; Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. Journal of Medical Virology 35:290–296
    [Google Scholar]
16. Macadam A. J., Arnold C., Howlett J., John A., Marsden S., Taffs F., Reeve P., FIamada N., Wareham K., Almond J., Cammack N., Minor P. D. 1989; Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172:408–414
    [Google Scholar]
17. Macadam A. J., Pollard S. R., Ferguson G., Skuce R., Wood D., Almond J. W., Minor P. D. 1993; Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates. Virology 192:18–26
    [Google Scholar]
18. Nomoto A. 1993; Recombinant polioviruses as candidates for oral live poliovaccines. Microbiological Immunology 37:169–174
    [Google Scholar]
19. Ren R., Moss E. G., Racaniello V. R. 1991; Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology 65:1377–1382
    [Google Scholar]
20. Rico-Hesse R., Pallansch M. A., Nottay B. K., Kew O. M. 1987; Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311–322
    [Google Scholar]
21. Stanway G., Hughes P., Westrop G. D., Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Almond J. W. 1986; Construction of poliovirus intertypic recombinants by use of cDNA. Journal of Virology 57:1187–1190
    [Google Scholar]
22. Supanaranond K., Takeda N., Yamazaki S. 1992; The complete nucleotide sequence of a variant of coxsackievirus A24, an agent causing acute hemorrhagic conjunctivitis. Virus Genes 6:149–158
    [Google Scholar]
23. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. 1984; Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. Journal of Molecular Biology 174:561–585
    [Google Scholar]
24. Westrop G. D., Wareham K. A., Evans D. M. A., Dunn G., Minor P. D., Magrath D. I., Taffs F., Marsden S., Skinner M. A., Schild G. C., Almond J. W. 1989; Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. Journal of Virology 63:1338–1344
    [Google Scholar]